Nanobiotix S.A. (NANO.PA) Stock Price
€8.42 0%
to add to portfolio
AI Score

-
Alternative
7 -
Fundamental
2 -
Technical
9
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Nanobiotix S.A., AI stock picks, stock alerts and much more.
NANO.PA AI Stock Analysis
AI stock analysis for NANO.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Nanobiotix S.A. (NANO.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Nanobiotix S.A. (NANO.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Nanobiotix S.A. (NANO.PA), currently trading at €8.42, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NANO.PA

-
Nanobiotix S.
-
Symbol
NANO.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
403.5M
Similar Stocks
![]() |
Valneva SE VLA.PA |
€5.05 2.4% |
5 |
![]() |
Financière de Tubize SA TUB.BR |
€160.6 0.4% |
8 |
![]() |
OSE Immunotherapeutics SA OSE.PA |
€6.32 0.5% |
6 |
![]() |
UCB SA UCB.BR |
€197.3 0.9% |
6 |
![]() |
Innate Pharma S.A. IPH.PA |
€2.01 1.9% |
5 |
News
NANO.PA Alternative Data
Web Traffic
Nanobiotix S.A. receives an estimated 4538 monthly visitors to nanobiotix.com.
-
Web Traffic
4538
-
Change from Previous Month
23.1%
-
3 Month Change
4.2%
-
YoY Change
4.2%
Twitter Followers
Nanobiotix S.A. has 3,807 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
3807
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Facebook Engagement
Nanobiotix S.A. has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Instagram Followers
Nanobiotix S.A. has 73 Instagram Followers on its main Instagram account, up by 4.3% over the last month.
-
Instagram Followers
73
-
Daily Change
0%
-
1 Month Change
4.3%
-
3 Month Change
4.3%
Youtube Subscribers
Nanobiotix S.A. has 198 subscribers on its main Youtube channel, up by 0.5% over the last month.
-
Youtube Subscribers
198
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
3.1%
Job Postings
Nanobiotix S.A. currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Nanobiotix S.A. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Nanobiotix S.A. has 148 employees, down by -0.7% over the last month.
-
LinkedIn Employees
148
-
Daily Change
0.7%
-
1 Month Change
0.7%
-
3 Month Change
1.3%
-
YoY Change
1.3%
News Mentions
Nanobiotix S.A. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
NANO.PA Financials
NANO.PA Key Metrics
-
Total Revenue
-€20.9M
-
Net Income
-€46.3M
-
Earnings per Share
-€0.98
-
Free cash flow
-€14.1M
-
EBITDA
-€38.4M
-
EBITDA Ratio
5.3083
-
Total Assets
€67.4M
NANO.PA 2-year Revenue & Income
NANO.PA 2-year Free Cash Flow
NANO.PA Technicals
NANO.PA SMA
NANO.PA RSI
FAQ
What's the current price of Nanobiotix S.A. (NANO.PA) Stock?
The price of an Nanobiotix S.A. (NANO.PA) share is €8.42.
What's the market cap of Nanobiotix S.A.?
The current market cap of Nanobiotix S.A. is 403.5M.
Should I buy or sell NANO.PA?
Nanobiotix S.A. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Nanobiotix S.A. is better viewed as a hold or accumulate position while waiting for further developments.
Is Nanobiotix S.A. a good investment?
The current analysis of Nanobiotix S.A.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Nanobiotix S.A.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Nanobiotix S.A. (NANO.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Nanobiotix S.A. stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Nanobiotix S.A. (NANO.PA) that investors often compare it to?
Nanobiotix S.A. (NANO.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Nanobiotix S.A.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Nanobiotix S.A.'s stock price to be around €8.9 in 2026. Starting from the current price of €8.42, this represents a 5.7% change in price, indicating a bullish outlook for the stock.
How to buy Nanobiotix S.A. (NANO.PA) Stock?
Nanobiotix S.A. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Nanobiotix S.A. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.